Dar Al Dawa Facilities

The company boasts the following facilities and operations that produce a wide variety of dosage forms including tablets, capsules, suspensions, ointments, creams, gels, suppositories, syrups, ophthalmic solutions and injectables under GMP and FDA regulations:

Jordan

1. Non-Betalactam Semi-Solids and Liquids Plant – producing a wide range of creams, ointments, gels, suppositories, ovules, liquids, eye drops and injectables.
2. Non-Betalactam Solids Plant – producing a wide range of capsules, tablets and suspensions.
3. Betalactams Plant – Producing capsules, tablets and suspension antibiotics.
4. Cephalosporines Plant – producing capsules, tablets, suspension and injectables.

Algeria

1. Dar Al Dawa – Algeria – marketing company to effectively market and distribute Dar Al Dawa’s products in Algeria.
2. Under-license production with SAIDAL for some of Dar Al Dawa’s products.
3. SAIDAR – A joint venture between Dar Al Dawa and SAIDAL for the manufacture of eye, ear and nose drop preparations for the Algerian and African markets.
4. Al Dar Al Arabia – a joint venture under construction between Dar Al Dawa (50%) and APM (50%) to manufacture ethical products for Algerian market.

Libya

1. Dar al Dawa-Libya – A joint venture under construction between Dar Al Dawa (60%) and a Libyan partner (40%), to establish a manufacturing facility for complementary product lines.

Tunisia

1. Under-license production with SAIPH for some of Dar Al Dawa’s products to be marketed in the Tunisian market.
2. Under-license production with SIPHAT for some of Dar Al Dawa’s products to be marketed in the Tunisian market.